Evaluation of Changes in the Immunological Microenvironment Surrounding Subcutaneous Breast Cancer Metastases After Liquid Nitrogen Cryotherapy (CRIMCAS)
Breast Cancer
About this trial
This is an interventional other trial for Breast Cancer focused on measuring cryotherapy, cytotoxicity
Eligibility Criteria
Inclusion Criteria: The patient must have given their free and informed consent The patient must be a member or beneficiary of a health insurance plan Patient with metastatic breast cancer with painful subcutaneous metastases. Patient eligible for cryotherapy. Therapeutic decision of antalgic and palliative treatment by cryotherapy taken in Pluridisciplinary Consultation Meeting. Patient available for 15-day follow-up. Exclusion Criteria: The subject is in a period of exclusion determined by a previous study The subject us unable to express their consent or refuses to sign the consent form The patient is under safeguard of justice or state guardianship
Sites / Locations
- CHU de NimesRecruiting
Arms of the Study
Arm 1
Experimental
Cryotherapy